Delivery Order SPE2DB22D6031-SPE2DB25FU7AH
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,809.26 on August 29, 2025, for the supply of Linezolid 600mg in quantities of 20 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set-aside and was competitively awarded, reflecting AmerisourceBergen's demonstrated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for 600 mg linezolid tablets in quantities of 20 per unit. This is a firm fixed-price contract with a ceiling value of $5,267.59 and an ultimate completion date of August 29, 2025. The contract was competitively awarded with no set-aside designation. Linezolid is an antibiotic used to treat serious bacterial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. This order, valued at $1,129.06 with a firm fixed price structure, represents a non-competed delivery against an existing contract vehicle and is scheduled for completion by August 26, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINEZOLID 600 MG TABLET 20S. The contract has a firm fixed price of $1,670.37 and a completion date of May 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567060100 LINEZOLID 600 MG TABLET 20S, a prescription medication, with an ultimate completion date of January 28, 2025 and a ceiling value of $4,726.51. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...
- This federal contract award, valued at $3,290.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Linezolid 600 mg tablets, a prescription medication, and has an ultimate completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a $7,488.12 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,781,655 Linezolid 600 mg tablets in 20-tablet packages. The contract has a period of performance through September 13, 2024. The award was not set aside for a particular business type. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
- The contract award is for Linezolid 600 mg tablets, a pharmaceutical product, with a total ceiling value of $7,276.71. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a delivery order contract, with a firm fixed price, to provide the specified medical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,031.18 firm fixed price contract is for the delivery of 4566377190 Linezolid 100 mg/5 ml suspension, a pharmaceutical product used to treat infections. The contract has an ultimate completion date of November 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINEZOLID 600 MG TABLET 20S. The contract, valued at $12,003.54, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB22D6031Indefinite Delivery Contract
- SPE2DB22D6031-SPE2DB25FU7AHDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,528.73 for Linezolid 600 mg tablets (20-count packaging) on September 12, 2025, with completion expected by September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Linezolid is a broad-spectrum antibiotic commonly used in military and federal healthcare systems for treating serious infections, including those resistant to other antibiotics. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract authorizes the distributor to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp has demonstrated consistent capability to fulfill federal requirements through competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/12/25 |